Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin
about
sameAs
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulantGestational diabetes mellitus in patients receiving long-term corticosteroid therapy during pregnancy.Current treatment of antiphospholipid syndrome: lights and shadows.Intravenous immunoglobulin G in women with reproductive failure: The Korean Society for Reproductive Immunology practice guidelines.Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.IVIG in APS pregnancy.Intravenous immunoglobulin in the management of lupus nephritis.Systematic review of the literature informing the systemic lupus erythematosus indicators project: reproductive health care quality indicators.Management of obstetric antiphospholipid syndrome.Infertility and pregnancy loss in euthyroid women with thyroid autoimmunity.Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.Immunotherapeutic strategies in antiphospholipid syndrome.The antiphospholipid syndrome: from pathophysiology to treatment.Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study.Rheological, hemostaseological changes during immunetherapy for prevention of HELLP-syndrome in a patient with elevated phospholipid antibodies.Immune modulation of i.v. immunoglobulin in women with reproductive failure.
P2860
Q24247000-56019452-1916-4EE9-A56E-A7FFDC24C032Q33372020-2B27589D-3C71-4112-A839-14A4087A01D3Q33423959-BD14E0CC-2A06-40BC-9AEB-5A3D75CFAC35Q33575554-2FE241A6-AE64-458C-95AF-44192370C448Q34476952-F284EDE8-1939-409C-823B-B6E6E9EB626EQ35918396-25C12C8C-BC10-4AF4-B17D-3EE35E968792Q36302368-1AB875FC-5AA4-46C0-B4F2-6412ECC454A5Q37782039-5BE94E76-6C39-4DA1-886B-C1D0A844B45BQ37959314-3DD7F73B-C44F-4E42-92ED-F3883C3C9502Q38029810-4A9F6844-6881-4B71-AEC5-65FF9BD1F131Q38092150-7DAF6842-0A82-4994-B911-2B114FB7E222Q38826804-964E33A8-91E2-49A7-9E09-5A4E8146E8B0Q38873953-FC519373-0938-4A49-9B3E-8C1AB8810387Q38876334-A5C40F46-B866-4773-A519-68903995640EQ46477214-903766E5-9D84-4878-9FA3-5D21CC5980AAQ50449309-D4D9A55B-CA27-431C-AFA5-3C3973D43431Q55094703-B1D14CF5-992D-4E01-9980-3852776C274C
P2860
Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@ast
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@en
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@nl
type
label
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@ast
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@en
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@nl
prefLabel
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@ast
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@en
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@nl
P2093
P921
P1476
Pregnancy outcome in recurrent ...... ednisone plus low-dose aspirin
@en
P2093
C Romanini
G Di Pierro
H Valensise
N Lazzarin
S Menghini
P356
10.1111/J.8755-8920.2001.450309.X
P407
P577
2001-03-01T00:00:00Z